SAYSD1 and cancer: This would explain an overexpression of lnc-SAYSD1-1 in an early stage of the tumor, such as that represented by Gleason ≤ 3+4, while the absence in subjects suffering from cancer with Gleason ≥ 4+3 could be understood as a positive prognostic factor.